Laboratory:Hachioji
- TOP
- viral infection test
- viral hepatitis
Laboratory:Hachioji
○viral hepatitis
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
HBV genotype
|
Serum
0.6 |
S09 ↓ A00 |
|
2-4 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
||
HBV DNA quantification (IU)
|
Serum
1.8 |
S5F |
(21 days) |
3-5 |
PCR (Real Time PCR) Real-time PCR |
Not detected (Log IU/mL) | |
HBs antigen (HQ)
|
Serum
0.6 |
S09 ↓ A00 |
(21 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 0.005 (IU/mL) | |
HBs antibody〔CLEIA〕
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 10.0 (mIU/mL) |
|
HBs antibody
|
Serum
0.2 |
S09 ↓ A00 |
|
2-4 |
PHA PHA (Passive hemagglutination) |
Less than 8 (times) | |
Hepatitis B core related antigen (HBcrAg)
|
Serum
0.5 |
S09 ↓ A00 |
|
2-5 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 2.1(LogU/mL) | |
HBc antibody (IgG)
|
Serum
0.3 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
C.O.I. less than 1.0 | |
IgM-HBc antibody
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
S/CO Less than 1.00 | |
HBc antibody
|
Serum
0.3 |
S09 ↓ A00 |
|
2-4 |
PHA PHA (Passive hemagglutination) |
Negative (less than 64) (times) | |
HBe antigen
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
C.O.I. less than 1.0 | |
HA antibody
|
Serum
0.7 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
INHIBITION Less than 60 (%) | |
HA antibody
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
See below | |
IgM-HA antibody
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
See below | |
HCV antibody (3rd generation)
|
Serum
0.7 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 1.0(-) (COI) |
|
By HCV group (grouping)
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
(Group) | |
HCV RNA core genotype
|
Serum
0.5 |
S3F,S5F |
(3 month) |
3-5 |
RT-PCR RT-PCR (Reverse transcriptase-polymerase chain reaction) |
Not detected | |
HCV RNA quantitative
|
Serum
1.8 |
S5F |
(21 days) |
3-5 |
RT-PCR (Real Time PCR) Real-time PCR |
Not detected (Log IU/mL) | |
HCV antigen (core protein)
|
Serum
0.8 |
S09 ↓ A00 |
|
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
Less than 3.0 (lower limit of quantification) (fmol/L) | |
IgA-HEV antibody (qualitative)
|
Serum
0.3 |
S09 ↓ A00 |
|
2-5 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
Negative | |
|
Serum
1.8 |
S5F |
|
PCR (Real Time PCR) Real-time PCR |
Not detected (Log IU/mL) | ||
|
Serum
0.3 |
S09 ↓ A00 |
|
CLIA CLIA (Chemiluminescent immunoassay) |
Less than 1.00 (-) | ||
|
Serum
0.5 |
S3F,S5F |
(21 days) |
10-14 | Direct sequencing method and Cycleave PCR method | ||
|
Serum
0.5 |
S3F,S5F |
(21 days) |
Please confirm in advance |
Direct sequence method Direct sequence method |
||
|
Serum
0.5 |
S3F,S5F |
(21 days) |
10-14 |
Direct sequence method Direct sequence method |
||
|
Serum
0.2 |
S09 ↓ A00 |
|
2-4 | Magnetized particle aggregation method (MAT method) | Negative (less than 8) (x) | |
|
Serum
0.5 |
S09 ↓ A00 |
|
CLIA CLIA (Chemiluminescent immunoassay) |
Less than 0.05 (IU/mL) | ||
|
Serum
0.5 |
S3F,S5F |
(21 days) |
4-10 | PCR-ELMA | ||
|
Serum
0.5 |
S3F,S5F |
(3 months) |
10-14 | Sanger method | AA2209-2248 Not detected (number of variants) |